5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis.

MLA

Czibere, A., et al. “5-Azacytidine for the Treatment of Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Who Relapse after Allo-SCT: A Retrospective Analysis.” Bone Marrow Transplantation, vol. 45, no. 5, May 2010, pp. 872–76. EBSCOhost, https://doi.org/10.1038/bmt.2009.266.

APA

Czibere, A., Bruns, I., Kröger, N., Platzbecker, U., Lind, J., Zohren, F., Fenk, R., Germing, U., Schröder, T., Gräf, T., Haas, R., & Kobbe, G. (2010). 5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis. Bone Marrow Transplantation, 45(5), 872–876. https://doi.org/10.1038/bmt.2009.266

Chicago

Czibere, A., I. Bruns, N. Kröger, U. Platzbecker, J. Lind, F. Zohren, R Fenk, et al. 2010. “5-Azacytidine for the Treatment of Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome Who Relapse after Allo-SCT: A Retrospective Analysis.” Bone Marrow Transplantation 45 (5): 872–76. doi:10.1038/bmt.2009.266.